Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: Potential for adoptive T cell immunotherapy
Authors:
- Cheng-Hao LiaoCLCheng-Hao Liao
- Chingwen YingCYChingwen Ying
- Chun-Jung ChangCCChun-Jung Chang
- Chun-Ming LinCLChun-Ming Lin
- 1 April 2006
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 119 (1) , 21-31
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15Nature Medicine, 2003
- Broadening of Epitope Recognition During Immune Rejection of ErbB-2-Positive Tumor Prevents Growth of ErbB-2-Negative TumorThe Journal of Immunology, 2003
- Dual-specific T cells combine proliferation and antitumor activityNature Biotechnology, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cellsEuropean Journal of Immunology, 2002
- Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapyBlood, 2001
- Progress in human tumour immunology and immunotherapyNature, 2001
- Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor ImmunityThe Journal of Immunology, 2000
- CD4 T Cells and Their Role in Antitumor Immune ResponsesJournal of Experimental Medicine, 1999
- Principles for Adoptive T Cell Therapy of Human Viral DiseasesAnnual Review of Immunology, 1995